High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for Prostate Cancer
52
about 5.9 years
18+
Male only
1 site in CA
What this study is about
This trial is testing whether high dose-rate brachytherapy and stereotactic body radiotherapy can treat prostate cancer. This treatment uses radiation to kill tumor cells, potentially with fewer doses over a shorter period compared to other methods.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive High-Dose Rate Brachytherapy
- 2.Receive Stereotactic Body Radiation Therapy
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Patient-reported genitourinary (GU) and gastrointestinal (GI) symptoms
Secondary: Distant disease-free survival, Overall survival, Patient-reported GI symptoms, Patient-reported GU symptoms, Progression-free survival, The acute grade >= 2 GI physician-scored toxicity, The acute grade >= 2 GU physician-scored toxicity, The late grade >= 2 GI physician-scored toxicity
radiation
Oncology